Chronic hepatitis C: future treatment
Astrid Wendt, Xavier Adhoute, Paul Castellani, Valerie Oules, Christelle Ansaldi, Souad Benali, Marc BourlièreDepartment of Hepato-Gastroenterology, Hôpital Saint-Joseph, Marseille, FranceAbstract: The launch of first-generation protease inhibitors (PIs) is a major step forward...
Saved in:
Main Authors: | Wendt A (Author), Adhoute X (Author), Castellani P (Author), Oules V (Author), Ansaldi C (Author), Benali S (Author), Bourlière M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspectivas futuras en el tratamiento de la hepatitis crónica C Future perspective in the treatment of chronic hepatitis C
by: J.V. Fernández-Montero, et al.
Published: (2011) -
Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010) -
Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014) -
Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine
by: Eduardo Guimarães Pereira, et al.
Published: (2016) -
Interaction of hepatitis C virus with the immune system in pregnant women with chronic hepatitis C
by: A. P. Tsibulkin, et al.
Published: (2019)